Digoxigenin [BSA]

Digoxin (DIG) is a steroid drug derived from the foxglove plant, widely used to treat heart failure and arrhythmias. As a clinical medication, digoxin exerts its effects by enhancing cardiac contractility and regulating heart rate. However, digoxin has a narrow therapeutic window, and its serum concentration must be precisely controlled to avoid toxic reactions and ensure therapeutic efficacy. Therefore, monitoring digoxin levels is particularly important. In addition to its pharmaceutical uses, digoxin's applications in biomedical research should not be overlooked, especially in molecular biology for labeling and probe techniques.

In molecular biology, digoxin is commonly used as a labeling molecule for non-radioactive nucleic acid probes. Traditional radioactive labeling methods are widely used due to their high sensitivity, but they come with drawbacks such as safety issues related to handling radioactive materials and slower signal detection. With advancements in technology, non-radioactive labeled probes have become a more popular choice. As a semi-hapten, digoxin's stability and high sensitivity make it an ideal alternative. Digoxin molecules chemically or enzymatically bind to nucleic acid probes, enabling their use in various molecular detection techniques. The application of digoxin primarily relies on its high affinity for other biomolecules. It forms digoxin-deoxyuridine triphosphate (DIG-dUTP) by binding to deoxyuridine triphosphate (dUTP) through a spacer arm. During probe preparation, digoxin molecules are incorporated approximately every 20 bases, which provides sufficient labeling signals. Once the target DNA is fixed on a nylon membrane, hybridization detection can be performed using digoxin-labeled probes. Typically, anti-digoxin antibodies conjugated with alkaline phosphatase are used to detect the hybrid complexes. Alkaline phosphatase catalyzes the redox reaction of the substrate 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium, generating a visual signal. Although digoxin-labeled probes demonstrate superior sensitivity compared to many other non-radioactive labels, their sensitivity is still lower than that of certain radioactive probes. To enhance probe sensitivity, the incorporation of digoxin molecules can be increased by adding tails at the 3' end. However, this method may reduce probe specificity, as the addition of non-specific nucleotides at the 3' end could interfere with the recognition of target sequences. Therefore, careful optimization of experimental conditions is necessary when using digoxin-labeled probes to ensure effective labeling and probe specificity.

The wide applications of digoxin also extend to its potential uses in non-radioactive systems. The advantages of non-radioactive probes include safety, stability, and cost-effectiveness. Compared to radioactive probes, digoxin-labeled probes do not require handling hazardous radioactive materials and can be reused multiple times without losing activity due to their stability. Additionally, digoxin-labeled probes can be used with various detection systems, including chemiluminescence and fluorescent dyes, broadening their application prospects in molecular biology research. Overall, digoxin serves as an effective non-radioactive labeling molecule that plays a significant role in the labeling and detection of nucleic acid probes. Through continuous optimization of labeling techniques and detection systems, digoxin-labeled probes will continue to showcase their unique advantages in molecular biology research, providing more reliable and safe solutions for scientific investigation and clinical diagnostics.

DIG [BSA] Conjugate
Digoxigenin Conjugated to BSA
Digoxigenin-Bovine Serum Albumin (BSA)
DIG-BSA